Preliminary data indicated that one of the major components of IBP-s was human estrogen-related receptor 1 (hERRI). We show here that several members of the steroid/thyroid hormone receptor superfamily, including testis receptor 2, thyroid receptor al in combination with retinoid X receptor a, chicken ovalbumin upstream promoter transcription factors 1 and 2 (COUP-TF1 and COUP-TF2), as well as hERR1, possess
the properties of IBP-s. These receptors bind specifically to hormone receptor binding sites present in the SV40 major late promoter. Recombinant COUP-TF1 specifically represses transcription from the SV40 major late promoter in a cell-free transcription system. Expression of COUP-TF1, COUP-TF2, or hERRl in monkey cells results in repression of the SV40 late promoter, but not the early promoter, in the absence ofthe virally encoded large tumor antigen. Overexpression of COUP-TF1 leads to a delay in the early-to-late switch in SV40 gene expression during the lytic cycle of infection. Thus, members of this superfamily can play major direct roles in regulating expression of SV40. Possibly, natural or synthetic ligands to these receptors can serve as antiviral drugs. Our findings also provide the basis for the development of assays to screen for the ligands to testis receptor 2 and hERR1.
Expression of the genome of the small primate DNA tumor virus simian virus 40 (SV40) is highly regulated. The late genes, which encode the virion proteins, are expressed efficiently only after the onset of viral DNA replication (1) . The early gene product, large tumor (T) antigen, accounts, in part, for activation of the late genes (2) . The cis-and trans-acting factors required for efficient transcription from the SV40 major late promoter (MLP) are (i) an upstream enhancer region (3) that binds multiple factors (4) and (ii) three proximal sequence elements (5) that interact with TFIID (6), DAP (7) , and, possibly, RNA polymerase II.
Wiley et al. (8) demonstrated that the presence in cells of sequence-specific transcriptional repressors was responsible for the replication dependence of SV40 late gene expression. They showed that (i) the repressor activity, designated IBP-s for initiator binding proteins of SV40, bound with high affinity to sequences located both directly at and 55 bp downstream of the major initiation site in the SV40 late promoter and (ii) these IBP-s binding sites were composed of direct repeats (DRs) similar to 5'-AGGTCA-3' in sequence and separated by 4 and 2 bp, respectively. Interestingly, the sequence 5'-AGGTCA-3' is the consensus half-site sequence for binding by members of the steroid/thyroid hormone receptor superfamily (9) . Partial amino acid sequence analysis revealed that the major 55-kDa component of IBP-s as purified from HeLa cells was identical to human estrogen-related receptor 1 (hERR1) (8) . Having been cloned solely on the basis of sequence similarity to estrogen receptor (10), hERR1's binding site specificity, ligand, and function were unknown.
The chicken ovalbumin upstream promoter transcription factors 1 and 2 (COUP-TF1 and COUP-TF2; also named ear-3 and ARP-1, respectively) and human testis receptor 2 (TR2) are other so-called "orphan" members of this superfamily (11) (12) (13) (14) (15) . Whereas the COUP-TFs have been shown to activate or repress transcription of a variety of genes (16) , the bindingsite specificity and function, as well as the ligand, of TR2 remain unknown.
We show here that COUP-TF1, COUP-TF2, and hERR1 possess all of the previously identified in vivo and in vitro functional activities of IBP-s, with COUP-TF1 being the second major component of IBP-s. We also show that (i) overexpression of COUP-TF1 delays the SV40 early-to-late switch in gene expression and (ii) thyroid receptor al (TRal) in combination with human retinoid X receptor a (hRXRa) and TR2 bind the + 1 and +55 IBP-s binding sites of the SV40 MLP, respectively. Thus, numerous members of the steroid/ thyroid hormone receptor superfamily can play major, direct roles in regulating expression of this primate DNA tumor virus.
MATERIALS AND METHODS
Oligonucleotides and Plasmids. The double-stranded oligonucleotides used (Fig. 1) were synthesized, annealed, and gel purified by standard protocols (17) . Plasmids pCOUP-TF1, pCOUP-TF2, and pRSh-COUP-TF1 (18) were gifts from M.-J. Tsai. Plasmids pRSV-hERR1 (10), pCDMa1(hTRa1) (19) , pSGhRXRa (20) , and pSG5-TR2 (21) were kindly provided by R. Evans, L. DeGroot, P. Chambon, and C. Chang, respectively. Plasmid pSV1773, containing an SV40 genome with a frameshift mutation in its VP1-coding region (22) , was used as "wild-type" (WT) SV40 in transfection experiments. Mutant pm322CXLS26 is a variant of pSV1773 in which the + 1 and +55 IBP-s binding sites have been inactivated (8) . In cell-free transcription reactions, the SV40 genomes lacked the 72-bp enhancer region as well (8) . Plasmid pSVE-luc, containing the luciferase reporter driven by the SV40 early promoter, was constructed by subcloning SV40 nt 5243-446 into the HindIII site of pGL-Basic (Promega). Plasmid pSVL-luc(WT) (23) an inactivated viral origin of DNA replication, and (iii) a frameshift mutation in the sequence encoding the aminoterminal region of T antigen (24) . Plasmid pSVL-luc(-3C) differs from pSV-luc(WT) solely by a G --C change at SV40 nt 322.
Gel Mobility-Shift Assays. Recombinant receptor proteins were synthesized in a coupled transcription-translation rabbit reticulocyte lysate system (Promega). Gel mobility-shift and supershift assays were performed as described (18) with minor modifications (23) . The COUP-TF-specific antiserum and the preimmune serum used in the supershift experiments were gifts from M.-J. Tsai (11) . Quantitative analyses were performed with a PhosphorImager (Molecular Dynamics).
Cell-Free Transcription Assays. Cell-free transcription reactions were performed essentially as described (8) . Final reaction volumes (50 ,lI) contained -150 ,ug of protein from HeLa cell nuclear extract and 200 ng of SV40 DNA. The DNA templates were preincubated, where indicated, with the specified amounts of in vitro synthesized recombinant COUP-TF1 prior to the addition of the nuclear extract. The resulting RNAs were analyzed by primer extension (22) . Synthetic oligonucleotides corresponding to SV40 nt 446-422 and 5178-5201 were used as primers for detecting late-and early-strand transcripts, respectively.
Transient-Transfection Assays. CV-1PD and HeLa cells were grown and transfections were performed as described (22) . Viral sequences were excised from their cloning vector and ligated to form monomer circles before transfection. The relative amounts of early and late SV40 RNA present at the indicated times after transfection were determined by quantitative Si nuclease mapping (3) . Viral DNA isolation and Southern blot analyses were performed as described (24) . Luciferase activities were determined with an assay kit (Promega) 54 (23) . The relative affinities of these proteins for these binding sites are remarkably similar to those observed previously with IBP-s (8, 25) .
To determine directly whether the COUP-TFs are major components of IBP-s, we examined whether IBP-s-DNA complexes could be specifically retarded in electrophoretic mobility by incubation with a COUP-TF-specific polyclonal antiserum (Fig. 1A) . Addition Fig. 1 for sequences) .
To confirm that a majority of the IBP-s binding activity present in HeLa cells does, indeed, contain COUP-TF crossreacting material, a HeLa cell nuclear extract was incubated with radiolabeled + 1 or +55 region probe in the absence or presence of the COUP-TF-specific antiserum (Fig. 3B) . The mobilities of two-thirds of the protein-DNA complexes formed on the +55 region probe were retarded by the COUP-TF-specific antiserum (Fig. 3B, lane 5) . In contrast, few of the protein-DNA complexes formed with the + 1 region probe were retarded (Fig. 3B, lane 2) (Fig. 4A) . Transcription from the WT SV40 MLP was repressed, with the extent of repression correlating with the amount of recombinant COUP-TF1 added (Fig. 4A, lanes 1-4) . Addition of comparable quantities of unprogrammed reticulocyte lysate did not affect transcription from the SV40 MLP (Fig. 4A, lanes 5-7) . No repression was observed when a variant of the SV40 MLP mutated in the + 1 and +55 IBP-s binding sites was used as template (Fig. 44, lanes 8-10) . On the other hand, addition of reticulocyte lysate, whether or not it was programmed to synthesize COUP-TF1, led to only slight, nonspecific repression of transcription from the SV40 early promoter present on the same plasmid DNA in the same reactions (Fig. 4A', lanes  1'-10') . Thus, COUP-TF1 can specifically repress transcription from the SV40 MLP and does so in a manner dependent upon the IBP-s binding sites.
To confirm the sequence specificity of this repression, cell-free transcription assays were also performed in the presence of competitor oligonucleotides (Fig. 4B) . As expected, the presence in trans of double-stranded oligonucleotide containing the optimal half-site sequence 5'-AG-GTCA-3' resulted in a 10-fold relief of repression by exogenous COUP-TF1 (Fig. 4B, lane 3 vs. lane 2) . However, addition of a similar oligonucleotide lacking this binding site sequence had no effect on transcription (Fig. 4B, (Fig. 1) . This overexpression of these orphan receptors. On the other hand, overexpression of the COUP-TFs or hERR1 had no effect.on transcription from the SV40 early promoter (Fig. 5, SVE-luc) . Therefore, their effects are promoter-specific, rather than indirect or a consequence of "squelching." Results similar to these were also obtained with HeLa cells (23) . These findings show that the COUP-TFs and hERR1 can specifically repress transcription from the SV40 late promoter under physiological conditions in living cells.
Overexpression of COUP-TF1 Delays the Early-to-Late Switch. To test directly whether members of the steroid/ thyroid hormone receptor-superfamily can affect regulation of the early-to-late switch in transcription of SV40 during its lytic cycle of infection, WT SV40 DNA was cotransfected into CV-1PD cells along.with pRSV-COUP-TF1 (Fig. 6) . As a control, cells were cotransfected in parallel with pRSV-0. Whereas the accumulation of the early-strand RNAs was unaffected by overexpression of COUP-TF1, accumulation of the late-strand RNAs was severely delayed ( Fig. 6A ; summarized in Fig. 6B) . Interestingly, the switch in the use of Binding assays were performed as described in the legend to Fig. 2 , using the oligonucleotides shown in Fig. 1 (Figs. 2 and 3 ) that the orphan receptors COUP-TF1 and COUP-TF2, as well as hERR1 (8) , are major components of IBP-s in HeLa cells. This result is consistent with the previous report that hERR1 copurifies from HeLa cells with the COUP-TFs (12) . We have demonstrated both in vitro (Fig. 4) and in vivo (Figs. 5 and 6) that recombinant COUP-TF1 represses transcription from the SV40 late promoter in a sequence-specific and titratable manner. Thus, COUP-TF1 has the functional activities attributed to IBP-s (8) .
The two isoforms of the COUP-TFs are expressed in many tissues, albeit at different levels. They are especially abundant in kidney cells (13, 14) , the primary tissue in which SV40
replicates (1 (26) have reported that expression of the COUP-TF genes exhibits spatial and temporal regulation. One hypothesis is that the COUP-TFs play roles in development and differentiation by turning off specific genes at appropriate times.
How might the COUP-TFs function as negative regulators of transcription? Plausible mechanisms include (i) competition for binding to the promoter with other, positively acting members of this superfamily, (ii) active repression via interaction with components of the general transcriptional machinery (e.g., TFIIB; ref. 27) , and (iii) competition for formation of heterodimers with other members of this superfamily.
The SV40 MLP provides an example of a promoter in which COUP-TF-responsive elements are located at and downstream of the transcription initiation site, rather than upstream of it. Thus, as an alternative, but not mutually exclusive, fourth plausible mechanism of repression, we hypothesize that binding of COUP-TF1 or COUP-like factors to the SV40 MLP could prevent formation of preinitiation complexes by directly competing with RNA polymerase II and general transcription factors for binding to the promoter. Data from order-ofaddition experiments are consistent with this latter hypothesis (23) .
hERR1 and the human TR2 were originally isolated on the basis of cross-hybridization with probes derived from the estrogen and androgen receptors, respectively (10, 15) . Thus, their ligands, sequence specificities, target genes, and functions remain unknown. Data presented here identify binding sites for these receptors on a functional promoter ( Fig. 5 ; Table 1 ). This information should be useful for both (i) determination of the sequence specificities of these receptors and (ii) development of simple assays to screen for their ligands and cellular target genes.
What are the effects of natural ligands and their synthetic analogs on expression of the SV40 late genes? Unfortunately, this question cannot yet be answered for the orphan receptors COUP-TFs, hERR1, and TR2. On the other hand, our finding that the heterodimer TRal/RXRa binds to the SV40 +1 site with high affinity makes some experiments with ligands possible. Preliminary data indicate that addition of the thyroid hormone 3,3',5-triiodothyronine to CV-1PD cells cotransfected with SV40 DNA and pTRa1 specifically relieves repression of the SV40 MLP by this receptor (23) . Thus, ligands to some steroid/thyroid hormone receptor superfamily members may be directly involved in regulating infection of animals by SV40 and related polyomavirus family members. Given our finding that numerous different receptors with distinct tissue distributions (10, 15, 16, 19) can bind the SV40 MLP (Table 1) , we speculate that different members of the steroid/thyroid hormone receptor superfamily may play roles in the regulation of SV40 late gene expression in different tissues.
Binding sites for members of the steroid/thyroid hormone receptor superfamily have been found in the promoters of numerous viruses, including the clinically relevant human immunodeficiency virus type 1 (28, 29) , human hepatitis B virus (ref. 30 ; X.-M. Yu and J.E.M., unpublished data), and herpes simplex virus 1 (31) . Thus, members of this receptor superfamily and their ligands may play direct, significant roles in modulating gene expression of many viruses. Possibly, the natural ligands of these receptors and analogs of them could be developed to serve as a new class of antiviral drugs.
